Investigating HLH
Investigating HLH, brought to you by Sobi Inc., is a podcast that takes a deep dive into the complex world of hemophagocytic lymphohistiocytosis, or HLH. As a rare and fatal disease that was once considered incurable, HLH presents with a range of severe signs and symptoms that make diagnosis difficult. Join us as we discuss insights about HLH from all angles with various experts in the field of hematology-oncology who have helped to advance the understanding and treatment of this devastating disease. When treating patients with HLH, knowledge is power—because knowing what to look for can save lives.
Latest episodes
Feb 25, 2025 • 16min
Monitoring Treatment Response
Kari Magee speaks with Dr Bethany Verkamp to discuss her recent research on evaluating treatment response to etoposide-based treatment in patients with HLH. Dr Verkamp is a hematology/oncology fellow in the Cancer and Blood Diseases Institute at Cincinnati Children's Hospital. Hear from Dr Verkamp about her research, findings, and important considerations for assessing patient response to first-line etoposide-based HLH therapy.Follow UsYouTube @Sobi-PharmaLinkedin @SobiPresented by Sobi Inc.https://www.sobi.com/usa/en
©2023 Sobi, Inc. All rights reserved. NP-32204 12/23
Jun 5, 2024 • 36min
Treating HLH
Dr. Saara Kaviany and Dr. Blachy J. Dávila Saldaña discuss treating HLH patients, focusing on controlling inflammation, hematopoietic stem cell transplants, and the importance of early recognition and targeted therapies for improved outcomes.
May 15, 2024 • 53min
Diagnosing HLH
Dr. Ashish Kumar and Dr. Scott Canna discuss the challenges of diagnosing HLH, emphasizing the critical importance of a prompt diagnosis. They explore the complexities of HLH diagnosis, including the evolution of diagnostic criteria and the significance of genetic testing. The podcast highlights the limitations of current guidelines and the need for real-time resources to navigate diagnostic uncertainties.
Apr 22, 2024 • 23min
Introduction to HLH
Dr. Michelle Hermiston, a pediatric hematologist-oncologist, discusses the history and advances in understanding HLH, focusing on mechanisms of hyperinflammation, classification of HLH, and the importance of collaborative care in managing this complex disease.
Nov 14, 2023 • 41sec
An Introduction to HLH
In this episode of Investigating HLH, Adam Narloch, a Thought Leader Liaison at Sobi, speaks with Dr Michelle Hermiston to discuss the history of HLH and advances that have been made in understanding this rare disease. Dr Hermiston is a pediatric hematologist-oncologist, a bone marrow transplant specialist, and the director of the Pediatric Immunotherapy Program at UCSF Benioff Children’s Hospital. Join us as we start our journey into the world of HLH!Follow UsYouTube @Sobi-PharmaLinkedIn @SobiPresented by Sobi Inc.https://www.sobi.com/usa/en
©2023 Sobi, Inc. All rights reserved. NP-32204 12/23
